Evaluation of Visual Outcomes of Monovision Patients Bilaterally Implanted With Nanoflex Intraocular Lenses
Status unconfirmed · Phase 4
Conditions studied: Patients Who Have Bilateral NanoFlex Implantation at Least 3 Months Previously
In brief
The purpose of this study is to look at how well you see the Nanoflex Intraocular lens placed in your eye.
Key facts
- Study ID
- NCT01279122
- Run by
- Innovative Medical
- People needed
- 100
- Starts
- 2011-01-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2011-02-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Male or female patients at least 18 years of age.
- Patients who have bilateral NanoFlex implantation at least 3 months previously.
- No significant ocular pathology causing DCVA to be less than 20/25 or causing significant visual loss.
- DCVA of 20/25 or better in both eyes.
- Spherical equivalent in the dominant eye to be +/-.50 or less and in the non-dominant eye to be between-1.00 and -1.87.
- Uncorrected VA in dominant eye 20/25 or better.
You may not qualify if…
- History of ocular trauma or prior ocular surgery (minor ocular trauma is allowed such as small superficial corneal scar not effecting vision; some prior ocular surgery is allowable so long as it has not impacted visual acuity.
- Amblyopia or strabismus, significant visual field loss, or posterior capsular opacifcation.
- Known pathology that may affect visual acuity; particularly retinal changes that affect vision (macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, etc.).
Where it is running
- Kenneth Lipstock — Richmond, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.